LOS ANGELES CAPITAL MANAGEMENT LLC - DENALI THERAPEUTICS INC ownership

DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 207 filers reported holding DENALI THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.17 and the average weighting 0.3%.

Quarter-by-quarter ownership
LOS ANGELES CAPITAL MANAGEMENT LLC ownership history of DENALI THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$949,021
-28.5%
46,002
+2.3%
0.00%
-20.0%
Q2 2023$1,326,652
+211.1%
44,956
+142.9%
0.01%
+150.0%
Q1 2023$426,401
-26.6%
18,507
-11.5%
0.00%
-33.3%
Q4 2022$581,285
-55.7%
20,902
-51.1%
0.00%
-57.1%
Q3 2022$1,312,000
+1.5%
42,741
-2.7%
0.01%
+16.7%
Q2 2022$1,293,000
-4.9%
43,919
+3.9%
0.01%
+20.0%
Q1 2022$1,359,000
-25.9%
42,252
+2.8%
0.01%
-28.6%
Q4 2021$1,833,000
-12.5%
41,092
-1.0%
0.01%
-30.0%
Q3 2021$2,095,000
-20.1%
41,522
+24.2%
0.01%
-16.7%
Q2 2021$2,622,000
+170.6%
33,432
+96.9%
0.01%
+200.0%
Q1 2021$969,000
-45.1%
16,975
-19.5%
0.00%
-50.0%
Q4 2020$1,765,000
+444.8%
21,076
+132.9%
0.01%
+700.0%
Q3 2020$324,000
-15.6%
9,051
-43.0%
0.00%
-50.0%
Q2 2020$384,000
+9.4%
15,880
-20.8%
0.00%0.0%
Q1 2020$351,00020,0500.00%
Other shareholders
DENALI THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Crestline Management, LP 19,462,500$339,037,00035.95%
Euclidean Capital LLC 323,749$27,117,0005.74%
Flagship Pioneering Inc. 2,730,263$228,687,0004.16%
Casdin Capital, LLC 1,310,000$109,726,0003.25%
A.R.T. Advisors, LLC 6,173$517,0002.39%
MARK ASSET MANAGEMENT LP 172,040$14,410,0001.73%
Temasek Holdings (Private) Ltd 4,410,457$369,420,0001.59%
Integral Health Asset Management, LLC 57,500$4,816,0001.43%
GILDER GAGNON HOWE & CO LLC 3,219,843$269,694,0001.34%
IRONWOOD INVESTMENT MANAGEMENT LLC 19,365$1,622,0000.95%
View complete list of DENALI THERAPEUTICS INC shareholders